| Name | Title | Contact Details |
|---|---|---|
Ed Carroll |
Senior Vice President Of Global Sales | Profile |
Ed Carroll |
Senior Vice President Of Global Sales | Profile |
Lifebank Inc is a Cedar Knolls, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
“We are a part of the circle of life. It`s as touching and important to be a part of the end of life as it is to be at the beginning. We provide our patients dignity, comfort and quality of life at the end of their journey. Our job is so much more about life than death! Being present during this sacred time is truly and honor, a calling. “ -Jane, LPH Registered Nurse **** Chapters Health System is committed to enhancing the lives of those affected by advancing age or illness. Through our comprehensive system of healthcare choices, we deliver expert care and heartfelt support to guide the community during the aging and end-of-life journey. From hospice and palliative care for adults and children suffering with life-threatening or life-limiting illnesses to in-home and community-based services for frail but independent seniors, Chapters Health offers a wide range of support services along life`s ever-changing landscape. By providing choices, education and guidance, Chapters Health helps enhance the lives of those affected by advancing age or illness. Chapters Health System includes Chapters Health Palliative Care, Chapters Health Pharmacy, Chapters Health Staffing, Good Shepherd Hospice, HPH Home Health, HPH Hospice and LifePath Hospice.
Claiborne County Hospital is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Tazewell, TN. To find more information about Claiborne County Hospital, please visit www.claibornehospital.org
EHP Inc is a Lancaster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.